Views Navigation

Event Views Navigation



Changing any of the form inputs will cause the list of events to refresh with the filtered results.

The Connection Between Mental Health and Opioid Use Disorder

Presenter(s): Mark Duncan, MD

There is a high prevalence of mental health disorders among those with opioid use disorder. However, many practitioners still find it difficult to distinguish between differential diagnoses that may have similar symptomatology, especially in regards to mental health and substance misuse. This webinar will enable participants to summarize the prevalence of common co-morbid mental illness, explain the relationships between concurrent mental health and opioid use disorder (OUD) and recognize risk factors associated with both mental health disorders and OUD.

Appropriate Interpretation of Urine Drug Screen Results

Presenter(s): Emily E. Leppien, PharmD, BCPS, BCPP

Controlled substances, including opioids, benzodiazepines and medical cannabis, are commonly prescribed for treatment of chronic pain. Urine drug screens (UDS) are often used in clinical practice to test for the presence of prescribed drugs in an effort to monitor compliance. This application-based webinar will provide participants the opportunity to further their ability to appropriately interpret UDS results through review of real-life patient case scenarios.

Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation

Presenter(s): Jennifer McNeely, MD

Substance use drives poor health outcomes in the general population. SUD continues to lead to more death and disability than any other preventable condition, with alcohol being the third leading cause of preventable death in the United States. Drug-related overdoses also continue to climb with > 108,000 overdose deaths per year as well as the leading all-cause mortality under the age of 50. Primary care is generally not thought of as a place to access mental health care, but it may be a critical tool in noticing substance use behaviors and proactively loop patients into needed care. This webinar aims to introduce screening tools that can be administered during primary care visits.

Smoking Cessation

The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals. Take advantage of these unique opportunities to engage your peers and get your … Continue reading "Smoking Cessation"

PCSS Exchange Session 1 – Explore, Part 1

Presenter(s): Debra Newman, PA-C, MPAS, MPH, Gavin Bart, MD, PhD, and Kristin Wason, NP-C, CARN
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.

Substance Use Disorders in Late Life

Presenter(s): Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD

The number of older adults is projected to exceed 72.1 million people by 2030 and members of the baby boomer generation have the highest rates of early life substance use which increases likelihood of substance use in later life. With rates of SUDs growing in older individuals, this population is experiencing mood and anxiety disorders, sleep disorders, cognitive impairments, sleep disruption, hepatic complications, and greater physical disability as co-morbid symptoms of substance use and aging. This webinar aims to improve awareness of the occurrence and impact of SUD as well as teach geriatric SUD screening tools. Finally, the webinar will offer recommendations for pharmacologic and psychosocial treatments for SUD in older adults.

How Adding a Clinical Pharmacist Improves Access to Addiction Care

Presenter(s): Ben Miskle, PharmD and Alison Lynch, MD, MS

There is a shortage of psychiatrists to meet the mental health needs of patients in the United States and this shortage was exacerbated by the COVID-19 pandemic. The incidence of substance use disorders (SUD) increased significantly during the pandemic and there is an insufficient number of physicians trained to meet patient needs. This gap creates problems across the health care system for providers, patients, and caregivers. One solution to this problem is integrating other members of the health care team to expand access to mental health and substance use treatments. Clinical pharmacists have extensive knowledge on pharmacologic treatment of SUD and are often underutilized resources. This presentation will highlight a successful model of how health care professionals can work together to coordinate and optimize care of patients living with SUD. The role of the psychiatric pharmacist as a partner in SUD care in different treatment settings will be explored and discussed.

PCSS Exchange Session 2 – Explore, Part 2

Presenter(s): Annie Potter, NP, CARN-AP, Gavin Bart, MD, PhD, and Grace Katie Bell, MSN, RN-BC, CARN, PHN
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.

Nurses’ Practices with People Experiencing Opioid Use Disorder

Presenter(s): Timothy J. Sowicz, PhD, RN

The purpose of this presentation is to present the findings from a narrative literature review that was conducted to understand nurses’ practices with persons with opioid use disorder (OUD). Nurses are a sizable portion of the health care workforce; therefore, understanding their unique, disciplinary contributions for people with OUD is important. Twenty-one studies were included in the review and most were non-experimental and conducted in Europe and North America. Nurses’ practices were described with various levels of specificity but aligned well with the scopes of practice of the American Nurses Society and the International Nurses Society on Addictions.

FAME Session 5: Co-Occurring Pain in the Outpatient Setting

Presenter(s): Abby Letcher, MD, FASAM; Angela Colistra, PhD, LPC, CAADC, CCS; Shanna Diaz, DO; and Dan Alford, MD

This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights, knowledge, and confidence.

Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches

Presenter(s): Jonathan Craig Allen, MD, FASAM, and Marc Fishman, MD

Research indicates a lack of training and programming specific to treating and managing co-occurring opioid and stimulant use disorders, despite the increased risk of overdose bolstered by the ever-changing and adulterated drug supply. While MOUD is the gold standard of care for treating OUD, there are no FDA-approved medications for treating stimulant use disorder, though behavioral therapies like contingency management have been well-studied. These challenges highlight the need to identify promising treatment strategies to ensure individuals with co-occurring opioid and stimulant use disorders are effectively engaged in care to prevent overdose. This session will equip BH providers and organizations in this space, including Community Behavioral Health Clinics (CCBHCs), with the tools necessary to effectively engage and provide quality, team-based care and services to individuals with co-occurring opioid and stimulant use disorders in order to improve health outcomes, reduce overdose risk, and support long-term recovery.